Severe heart failure increases mortality risk in COVID-19 patients

Of COVID-19 patients with heart disease who are admitted to the hospital, patients with severe heart failure are found to have the highest mortality rate. COVID-19 patients with other heart conditions, including a previous myocardial infarction, appear to have a lower mortality rate. Researchers, brought together by the Dutch CardioVascular Alliance (DCVA), published this today online at The Dutch Heart Foundation funded this research.

Increased mortality with increasing age and multiple diseases

Mortality caused by COVID-19 increases with age. Of the COVID-19 patients admitted to hospital, the mortality rate at the younger age group (18-25 years) is 2% while the oldest age group (> 85 years) shows a mortality rate of 41.5%. Because patients with cardiovascular disease are often older and may have other diseases, mortality is also higher for this group (30.7%) compared to people without cardiovascular disease (15.9%). Furthermore, people who end up in intensive care more often have heart complications. In-hospital heart complications are also more common in hospitalised COVID-19 patients who had pre-existing heart disease.

Increased mortality with heart failure

Regardless of age and gender, COVID-19 patients with severe heart failure are 37% more likely to die compared to other COVID-19 patients admitted to the hospital. The effect of other heart conditions, including a previous myocardial infarction, seems less significant. It was previously recorded that corona patients with heart failure are more likely to be hospitalised.

COVID-19 complaints vary with age

The researchers did not see any differences in COVID-19 complaints between hospitalised patients with and without heart disease. They did see differences between age groups. The most common symptoms in COVID-19 patients between the ages of 45 and 65 are fever, cough, and shortness of breath. Fever and breathlessness were less common in other age groups. Complaints of loss of smell occurred mainly in younger patients and much less in patients over 65 years of age.

The researchers recorded the disease progression of nearly 11,000 corona patients admitted to hospitals in 16 different countries. They compared data from patients with and without heart disease to gain more insight into the role of these diseases in COVID-19 patients. The data was collected between March and November 2020. Patients were followed from hospital admission to discharge.

Follow-up research into long-term effects of COVID-19 on the heart

Scientists conducting this research will also investigate the long-term effects of COVID-19 on the heart. To study this, they will make heart ultrasounds and take questionnaires from COVID-19 patients who have been admitted to the hospital. This way they want to determine whether there is an increased risk of heart disease in the years after hospitalisation and how often there are long-term complaints such as palpitations and chest pain. Patients and doctors see this as one of the most important areas requiring further research.


These results come from the CAPACITY-COVID and the LEOSS registration. CAPACITY-COVID is a collaboration of the patient association Harteraad, the Dutch Heart Foundation, the Dutch Heart Registration (NHR), the Dutch Association for Cardiology (NVVC), the Netherlands Heart Institute (NLHI) and the Working Group Cardiological Centers Netherlands (WCN). Together they are part of a total of nineteen partners, including research and healthcare organizations that have joined forces in the Dutch CardioVascular Alliance (DCVA). In this collaboration, the partners work together within the DCVA and raise money to accelerate solutions for cardiovascular diseases.

More news

Call for Einthoven prizes
Call for proposals - RECONNEXT fellowship grant
Call for proposals - Help understanding the PLN disease
Two amazing days!
Human Cardiac Tissue available for Cardiovascular Research
Call for Fellowships 2022
Results of the Fellowship of Pieterjan Dierickx
Anniversary Year for the NLHI in 2022 / Picture Competition
Einthoven Dissertation prizes 2021
Call for proposals - Help understanding the PLN disease
Results of the Fellowship of Jan Willem Buikema
Register for the 5th DCVA Translational Cardiovascular Research Meeting
Severe heart failure increases mortality risk in COVID-19 patients
Out of the Box Call: HBCx and CVON Early HFPEF - She Predicts
NLHI - NVVC Einthoven Prizes
Call for proposals - Help curing PLN disease
Members for the Program Committee wanted
Successful 4th Translational Cardiovascular Research Meeting
4th Translational Cardiovascular Research Meeting, 25 June 2020 – ONLINE
In Memoriam: Hein Wellens
Launch of the first Dutch donor biobank for heart tissue
NLHI supports research into COVID-19-related cardiovascular complications
Online training courses
DCVA registry for COVID-19 and cardiovascular complications
Call Young Talent Grant DOSIS/ARENA Prime
The Orchestra of Dutch Cardiology
Change of the board of the Netherlands Heart Institute
In Memoriam: Jan Weijers
Successful 3rd Translational Research Meeting
Workshop "Video Production with your Smartphone"
Risk calculator to preven sudden cardiac death
Call for Pitches
Young@Heart board appointed
Call for proposals: Help curing PLN disease
Young Talent Grant DOSIS/ARENA Prime
First 5 sessions published
Registration now open!
Second key note lecture confirmed
Roger Foo to lecture at our Congres
PLN disease in Eenvandaag
Promoting Transparency in Preclinical Research
Isabelle van Gelder on the RACE studies
VIDI for Rik Vos
Call for Posters
Scientific session "Promoting transparency in preclinical research"
ISO9001:2015 certification for Durrer Center
Congress 2018
VICI award for Van der Velden
Life Time Achievement Award for Walter Paulus
Website hereditary cardiac disease
PLN-information day 2017
Success for RACE III study
Call for proposals: Fellowship 2017 ‘cure PLN disease by gene-editing’
Cardiologen fietsen voor onderzoeksbudget erfelijke hartspierziekte PLN
1st Translational Research Meeting of the Netherlands Heart Institute
Fellowships awarded
Poster Prizes 1st Translational Research Meeting
PLN project awarded
Michiel de Graaf wins Einthoven prize 2017
Young @ Heart - Strategic Alliances
Recognition for the Netherlands Heart Institute
ERA-CVD call atherosclerosis
KNAW acknowledgement Netherlands Heart Institute
New COACT web site
Food & Cardiovascular Health
Succesful Young@Heart Event
Einthoven dissertation Prize 2015
Master class with Loren Field: "Don’t be afraid to try something new"
Nominations Einthoven Prize announced

Tel: 088-2333600      E-mail:      Twitter: @nl_heart      Facebook: @netherlandsheartinstitute